Literature DB >> 6192999

Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third-party H-2 alloantigens.

V Holán, N A Mitchison.   

Abstract

Specific suppressor T cells (Ts) were induced in vitro by incubation of mouse spleen/lymph node cells with allogeneic heat-treated cells. These Ts inhibit mixed lymphocyte reaction (MLR) in a haplotype-specific manner. Ts also suppress cell proliferation induced by third-party H-2 alloantigens provided these are expressed on the same cell surface as at least some of the H-2 antigens used for Ts activation. Ts activated by H-2 plus non-H-2 alloantigens suppress an MLR induced by irrelevant H-2 alloantigens if these are expressed on the same cell surface as the non-H-2 alloantigens used for Ts activation. Products of the H-2 region or non-H-2 alloantigens which are not able to stimulate cell proliferation do not activate Ts. These Ts are first demonstrable after 4 days of incubation of lymphoid cells with heat-treated allogeneic cells and they inhibit MLR only if added at the very beginning of the culture. Exogenous interleukin 2 does not overcome suppression and the suppression is not due to a cytotoxic effect, since heat-treated cells do not elicit cell proliferation or cytotoxic cells. Moreover, the specific Ts differ in their Thy-1+,Ly-1+,2-phenotype from Ly-2+ allospecific cytotoxic cells. Thus specific Ts could be induced in vitro, which demonstrate linked suppression for third-party H-2 alloantigens provided these are expressed on the same cell surface as the antigens used for Ts activation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192999     DOI: 10.1002/eji.1830130809

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

Review 1.  Regulatory T cell-mediated transplantation tolerance.

Authors:  Ankit Bharat; Ryan Courtney Fields; T Mohanakumar
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 2.  Special regulatory T-cell review: Suppressors regulated but unsuppressed.

Authors:  Judith A Kapp
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

3.  Induction of specific transplantation immunity by oral immunization with allogeneic cells.

Authors:  V Holán; A Zajícová; M Krulová; J Plsková; J Fric; M Filipec
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

4.  Ly 1+2- suppressor T cells down-regulate the generation of Ly 1-2+ effector T cells during progressive growth of the P815 mastocytoma.

Authors:  R J North; E S Dye
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

5.  Selective in-vitro activation of BALB/c T suppressor lymphocytes specific for syngeneic ADJ-PC-5 plasmacytoma cells.

Authors:  H D Haubeck; I Minkenberg; E Kölsch
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

6.  Allospecific suppression without requirement for participation of Ly 2+ cells.

Authors:  V Holán; N A Mitchison
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

7.  Antisuppression: a novel pathway in T cell regulation of B cell function.

Authors:  F Paraskevas; S T Lee; A A Maghazachi
Journal:  Surv Immunol Res       Date:  1984

8.  Grass-specific CD4(+) T-cells exhibit varying degrees of cross-reactivity, implications for allergen-specific immunotherapy.

Authors:  L D Archila; J H DeLong; E Wambre; E A James; D M Robinson; W W Kwok
Journal:  Clin Exp Allergy       Date:  2014-07       Impact factor: 5.018

Review 9.  The role of the FOXP3 transcription factor in the immune regulation of allergic asthma.

Authors:  Carsten B Schmidt-Weber; Kurt Blaser
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.919

10.  Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. Mediation of specific suppression by T helper/inducer cells.

Authors:  B M Hall; M E Jelbart; K E Gurley; S E Dorsch
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.